New York, NY -- (SBWIRE) -- 10/25/2013 -- King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Today We bring special trend analysis of following stocks: Monolithic Power Systems, Inc. (NASDAQ:MPWR), Deckers Outdoor Corp (NASDAQ:DECK), Zynga Inc (NASDAQ:ZNGA), Dynavax Technologies Corporation (NASDAQ:DVAX)
Monolithic Power Systems, Inc. (NASDAQ:MPWR) made a new 52-week high of $32.90 earlier today following an upgrade from Oppenheimer, which improved its ratings on the fabless semiconductor company from Market Perform to Outperform, in a research note sent to investors on Friday. MPWR has a market capitalization of $1.20 billion and P/E ratio of 84.44.
What was the Moving Force behind MPWR On Bullish Run? Read This Research Report on MPWR
Deckers Outdoor Corp (NASDAQ:DECK) jumped more than 14 percent today after the footwear and accessories maker said that it earned $33.06 million or $0.95 per share for the third-quarter, versus $43.06 million or $1.18 per share, last year. Q3 revenue jumped 3 percent to $386.73 million. Analysts were predicting profit of $0.72 per share on $385.95 million in revenue. DECK stock has a 52-week range of $28.53 to $69.90. The company has a market capitalization of $2.33 billion and P/E ratio of 21.59.
Will DECK Continue To Move Higher? Find Out Here
Zynga Inc (NASDAQ:ZNGA) jumped more than 13 percent in the current trading session after Piper Jaffray lifted its price target for the provider of social game services to $4 per share following its strong quarterly results. ZNGA stock has a 52-week range of $2.09 to $4.05. The company has a market capitalization of $3.21 billion.
Is ZNGA a Solid Investment at These Levels? Read This Report For Details
Dynavax Technologies Corporation (NASDAQ:DVAX) rose 5.13 percent to $1.23 today on traded volume of 9.64 million shares. The stock has a 52-week range of $0.98 to $5.00. Dynavax is a clinical-stage biopharmaceutical firm that is engaged in the discovery and development of products to cure inflammatory and infectious diseases. The company has a market capitalization of $223.25 million
Where DVAX is Headed Exactly? Find out in This Trend Analysis Reports
About King Penny Stocks
King Penny Stocks provides up to the minute dissemination of news while reporting on stocks that are actively traded in the small cap arena whether trading on the Nasdaq small caps, AMEX or the OTC markets. Since performance is key in our industry, it’s no wonder why our ground breaking alerts on active stocks have brought us to the forefront of this industry. Our due diligence on trend analysis has caught the attention of the very best chart technicians in the business.
King Penny Stocks is an elite financial community for investors and traders alike who are looking to potentially gain financial freedom through the markets on undervalued companies and “in-play” momentum penny stocks. Get detailed breakdowns of major trends impacting the markets.
Our newsletter, Press Release and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company.
An individual should never invest in the securities of any of the companies profiled based solely on information contained in our report. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research. This report/release/advertisement is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation.
Read our Full Disclaimer at: http://kingpennystocks.com/disclaimer/
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)